Literature DB >> 240522

An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma.

J K Huttunen, C Ehnholm, P K Kinnunen, E A Nikkilä.   

Abstract

A new method for the selective measurement of postheparin plasma lipoprotein lipase and hepatic lipase is described and validated. The activity of lipoprotein lipase is determined at 0.1 M NaCl after removal of hepatic lipase by specific antiserum, and the hepatic lipase is assayed in a medium containing 1.0 M NaCl but no additional serum. The optimal conditions for the determination of the two postheparin plasma triglyceride hydrolases were shown to be similar to those described for the purified enzymes. The new assay methods are simple, accurate and highly specific for the two lipase activities. VLDL and LDL do not interfere with the measurement, making the methods suitable for studies of patients with various hyperlipidemias. More than 90% of the total triglyceride hydrolase activity in postheparin plasma is precipitated with antisera raised against purified human postheparin plasma hepatic lipase and bovine milk lipoprotein lipase. The time and dose dependence of the two postheparin plasma lipase responses differ. For optimal activity of both enzymes, plasma taken 15 minutes after intravenous administration of 100 I.U./kg of heparin, should be used. The activity of postheparin plasma lipoprotein lipase and hepatic lipase in 12 young, healthy males is reported.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240522     DOI: 10.1016/0009-8981(75)90055-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  28 in total

1.  Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol.

Authors:  P N Demacker; M J Mol; A F Stalenhoef
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-/-Gpihbp1-/- mice.

Authors:  Emily M Cushing; Kelli L Sylvers; Xun Chi; Shwetha K Shetty; Brandon S J Davies
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

3.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Authors:  E Tahvanainen; M Syvanne; M H Frick; S Murtomaki-Repo; M Antikainen; Y A Kesaniemi; H Kauma; A Pasternak; M R Taskinen; C Ehnholm
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

5.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.

Authors:  J S Reitman; F C Kosmakos; B V Howard; M R Taskinen; T Kuusi; E A Nikkila
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

9.  Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.

Authors:  E A Nikkilä; R Ylikahri; J K Huttunen
Journal:  Proc R Soc Med       Date:  1976

10.  Heparin-induced release of extracellular superoxide dismutase to human blood plasma.

Authors:  K Karlsson; S L Marklund
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.